- Mar 25, 2001
- 19,275
- 1,361
- 126
Editorial from the NY Times
I hate how they rule out the most obvious solution right from the start. Financial incentives are frowned upon but they don't say why. I can see where having organ markets can lead desperate people to make rash decisions to sell a kidney while they are still alive, but why not give people a few thousand dollars to spend while they are alive in exchange for using their organs (kidneys in this case) once they die? Where does the ethical quarrel lie in that?
I hate how they rule out the most obvious solution right from the start. Financial incentives are frowned upon but they don't say why. I can see where having organ markets can lead desperate people to make rash decisions to sell a kidney while they are still alive, but why not give people a few thousand dollars to spend while they are alive in exchange for using their organs (kidneys in this case) once they die? Where does the ethical quarrel lie in that?
